'Acting' At CDRH: Two Top Device Offices Now Run By Interim Directors
This article was originally published in The Pink Sheet Daily
An update on CDRH's management structure.
You may also be interested in...
Christy Foreman is taking an associate director role in FDA’s Center for Tobacco Products, leaving a vacancy at the top of the Office of Device Evaluation. CDRH Chief Scientist William Maisel will fill in while the device center seeks a replacement.
CDRH Deputy Center Director for Policy Nancy Stade will leave the agency at the end of the summer.
The US agency sent a letter to health-care providers spotlighting its analysis of the increasing numbers of adverse events linked to surgical staplers and implantable staples, and its plans for a draft guidance on labeling and an advisory panel meeting to consider a 510(k) requirement for the products.